BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21505085)

  • 1. From mouse to man: predictions of human pharmacokinetics of orally administered docetaxel from preclinical studies.
    Koolen SL; van Waterschoot RA; van Tellingen O; Schinkel AH; Beijnen JH; Schellens JH; Huitema AD
    J Clin Pharmacol; 2012 Mar; 52(3):370-80. PubMed ID: 21505085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity.
    van Waterschoot RA; Lagas JS; Wagenaar E; van der Kruijssen CM; van Herwaarden AE; Song JY; Rooswinkel RW; van Tellingen O; Rosing H; Beijnen JH; Schinkel AH
    Cancer Res; 2009 Dec; 69(23):8996-9002. PubMed ID: 19920203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein, multidrug-resistance associated protein 2, Cyp3a, and carboxylesterase affect the oral availability and metabolism of vinorelbine.
    Lagas JS; Damen CW; van Waterschoot RA; Iusuf D; Beijnen JH; Schinkel AH
    Mol Pharmacol; 2012 Oct; 82(4):636-44. PubMed ID: 22767610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats.
    Choi YH; Suh JH; Lee JH; Cho IH; Lee MG
    J Pharm Pharmacol; 2010 Aug; 62(8):1084-8. PubMed ID: 20663044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
    Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
    Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4alpha, and constitutive androstane receptor with docetaxel pharmacokinetics.
    Tham LS; Holford NH; Hor SY; Tan T; Wang L; Lim RC; Lee HS; Lee SC; Goh BC
    Clin Cancer Res; 2007 Dec; 13(23):7126-32. PubMed ID: 18056193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer.
    Koolen SL; Oostendorp RL; Beijnen JH; Schellens JH; Huitema AD
    Br J Clin Pharmacol; 2010 May; 69(5):465-74. PubMed ID: 20573082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model.
    Hendrikx JJ; Lagas JS; Song JY; Rosing H; Schellens JH; Beijnen JH; Rottenberg S; Schinkel AH
    Int J Cancer; 2016 Feb; 138(3):758-69. PubMed ID: 26297509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danshen extract does not alter pharmacokinetics of docetaxel and clopidogrel, reflecting its negligible potential in P-glycoprotein- and cytochrome P4503A-mediated herb-drug interactions.
    Lee JH; Shin YJ; Kim HJ; Oh JH; Jang YP; Lee YJ
    Int J Pharm; 2011 May; 410(1-2):68-74. PubMed ID: 21421030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin-induced diabetic rats.
    Lee JH; Lee A; Oh JH; Lee YJ
    Biopharm Drug Dispos; 2012 Nov; 33(8):474-86. PubMed ID: 22936118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain Disposition and Oral Availability of the Novel Taxane Cabazitaxel (Jevtana) in Mice.
    Tang SC; Kort A; Cheung KL; Rosing H; Fukami T; Durmus S; Wagenaar E; Hendrikx JJ; Nakajima M; van Vlijmen BJ; Beijnen JH; Schinkel AH
    Mol Pharm; 2015 Oct; 12(10):3714-23. PubMed ID: 26317243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual and combined roles of CYP3A, P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxel.
    van Waterschoot RA; Lagas JS; Wagenaar E; Rosing H; Beijnen JH; Schinkel AH
    Int J Cancer; 2010 Dec; 127(12):2959-64. PubMed ID: 21351274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice.
    Press RR; Buckle T; Beijnen JH; van Tellingen O
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):819-25. PubMed ID: 16163538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxanes: old drugs, new oral formulations.
    Jibodh RA; Lagas JS; Nuijen B; Beijnen JH; Schellens JH
    Eur J Pharmacol; 2013 Oct; 717(1-3):40-6. PubMed ID: 23660368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of morin on the pharmacokinetics of docetaxel in rats with 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumors.
    Yang SH; Lee JH; Lee DY; Lee MG; Lyuk KC; Kim SH
    Arch Pharm Res; 2011 Oct; 34(10):1729-34. PubMed ID: 22076773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous-to-oral switch in anticancer chemotherapy: a focus on docetaxel and paclitaxel.
    Koolen SL; Beijnen JH; Schellens JH
    Clin Pharmacol Ther; 2010 Jan; 87(1):126-9. PubMed ID: 19924122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of ketoconazole on the fecal and urinary disposition of docetaxel.
    Engels FK; Loos WJ; Mathot RA; van Schaik RH; Verweij J
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):569-79. PubMed ID: 17256132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.
    Bardelmeijer HA; Ouwehand M; Buckle T; Huisman MT; Schellens JH; Beijnen JH; van Tellingen O
    Cancer Res; 2002 Nov; 62(21):6158-64. PubMed ID: 12414642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel.
    Cox MC; Low J; Lee J; Walshe J; Denduluri N; Berman A; Permenter MG; Petros WP; Price DK; Figg WD; Sparreboom A; Swain SM
    Clin Cancer Res; 2006 Aug; 12(15):4636-40. PubMed ID: 16899612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism.
    van Herwaarden AE; Wagenaar E; van der Kruijssen CM; van Waterschoot RA; Smit JW; Song JY; van der Valk MA; van Tellingen O; van der Hoorn JW; Rosing H; Beijnen JH; Schinkel AH
    J Clin Invest; 2007 Nov; 117(11):3583-92. PubMed ID: 17975676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.